Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 1718 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 1732 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 1766 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 1869 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 1919 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 1949 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2051 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2279 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2407 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2421 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2453 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2595 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 2732 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3063 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3071 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3111 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3137 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3231 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3443 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3647 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 3806 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 4158 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 4163 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 4681 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 4757 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 4776 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 4884 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5003 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5206 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5284 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5321 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5343 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5461 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5485 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5546 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5660 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 5774 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 6022 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 6242 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 6259 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 6526 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 6873 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 7067 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 7419 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 7464 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 7566 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 7945 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 8001 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 8140 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 8947 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 9162 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 9759 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 10066 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 10274 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 10479 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 11089 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 11284 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 13459 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 13951 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | 14304 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | Borderline Pressures | Female | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | Borderline Pressures | Male | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | Healthy | Female | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | Healthy | Male | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | LowRisk | Female | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | LowRisk | Male | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | Normal Pressures | Female | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | PAH | Female | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | No | PAH | Male | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | Borderline Pressures | Female | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | Borderline Pressures | Male | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | Healthy | Female | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | Healthy | Male | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | LowRisk | Female | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | LowRisk | Male | Non-invasive | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | Normal Pressures | Female | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | PAH | Female | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+ | Peak area normalized | Yes | PAH | Male | Cath | |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 11069 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 13782 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 14213 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 15749 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 16078 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 17130 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 17324 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 18000 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 18079 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 18670 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 19825 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 22027 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 22083 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 22209 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 23588 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 23938 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 24730 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 25057 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 25170 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 25868 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 26131 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 27044 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 27048 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 27918 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 28296 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 29882 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 29988 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 30532 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 30553 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 30811 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 31258 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 31803 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 32102 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 32427 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 32817 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 35749 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 35917 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 36913 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 37084 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 38626 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 38706 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 38928 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 40950 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 41787 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 43445 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 43665 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 43741 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 44175 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 44975 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 45176 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 45432 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 45820 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 46201 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 46380 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 48539 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 49555 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 52264 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 53515 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 55153 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 55518 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 57201 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 58038 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 58070 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 58288 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 58354 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 58386 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 58799 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 60889 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 60959 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 61010 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 61027 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 61294 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 61892 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 62004 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 62077 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 64697 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 65503 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 65506 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 65713 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 66069 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 66865 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 67014 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 68635 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 68881 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 69240 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 70013 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 70724 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 71872 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 72503 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 73526 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 75789 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 75983 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 76083 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 76918 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 77112 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 78136 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 78880 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 78907 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 78923 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 80337 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 80688 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 81855 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 82043 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 82733 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 83582 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 83904 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 85224 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 85347 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 85769 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 85859 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 87916 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 89675 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 90451 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 93374 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 94393 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 94393 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 94393 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 95386 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 95777 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 96152 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 97699 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 98335 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Return to search page